Good Vita / The learning library

Semax

A research peptide often included in cognition-related online discussions.

Educational information only. No medical advice or treatment recommendations.

← Back to the full library

Research compounds Animal study Brain research

Also discussed as: Heptapeptide

What it is and how it works

Semax is a synthetic peptide derived from an ACTH fragment with an added peptide sequence. The cited research tested immune- and vascular-related gene expression after experimental cerebral ischemia in rats. That context is substantially different from healthy-person focus or productivity claims.

Source for the mechanism context →

A closer look at the cited evidence

Animal study

This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.

Study or assessment
2014 — Semax gene-expression study in rat cerebral ischemia
Design
Genome-wide transcriptional analysis in an experimental rat model.
Who or what was studied
Rats with experimentally induced focal brain ischemia.
What was observed
Semax altered expression of genes associated with immune and vascular processes.
Limits of interpretation
The study does not establish improved cognition in healthy people or a clinically appropriate intervention for stroke. It is a selected preclinical example.
Read the cited study or assessment →

What the evidence means

A proposed cognitive effect is not the same as established treatment effectiveness.

Approval and regulatory context

Not an FDA-approved cognitive wellness medicine.

Safety and uncertainty

Safety evidence for proposed routes is limited.

What remains uncertain

The connection between molecular changes and durable human benefit requires direct research. Results in a disease model should not be repackaged as evidence for a different population, condition, or product.

These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.

Sources behind this overview

Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.

Start Your Assessment